You are here

antibiotics

Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11

Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11

Endpoints

Flag link:

The antibiotics R&D effort is broken. Here's one market solution that might fix it

The antibiotics R&D effort is broken. Here's one market solution that might fix it

Endpoints

Flag link:

Novartis shares data on discontinued antibiotic research

Novartis shares data on discontinued antibiotic research

BioCentury

Flag link:

Genentech develop antibiotic with potential to lead to new class of antibiotics

Genentech develop antibiotic with potential to lead to new class of antibiotics

Pharmaforum

drug development

antibiotic resistance

Flag link:

Eisai, Takeda and GARDP hunt for new antibiotics

Eisai, Takeda and GARDP hunt for new antibiotics

Pharmaforum

Flag link:

Experimental treatment appears effective against gonorrhea in small study

Experimental treatment appears effective against gonorrhea in small study

Stat

Flag link:

Paratek caps 20-year R&D journey with FDA OK for its broad spectrum antibiotic — time to talk launch

Paratek caps 20-year R&D journey with FDA OK for its broad spectrum antibiotic — time to talk launch

Endpoints

Flag link:

MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics

MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics

CP WIre

MicuRx Pharmaceuticals

contezolid acefosamil

Flag link:

MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics

MicuRx Pharmaceuticals

contezolid acefosamil

Flag link:

Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases

Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases

CP Wire

Boehringer Ingelheim

drug development

Flag link:

Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections

Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections

Xconomy

Tetraphase Pharmaceuticals

complicated intra-abdominal infections

Flag link:

Paratek clears one last big hurdle on the way to an FDA marketing decision for antibiotic

Paratek clears one last big hurdle on the way to an FDA marketing decision for antibiotic

Endpoints

advisory panels

Flag link:

Paratek antibiotic not inferior to current treatments: FDA staff

Paratek antibiotic not inferior to current treatments: FDA staff

Reuters

aminomethylcyclines

Flag link:

Urgent care centers often prescribe unnecessary antibiotics

Urgent care centers often prescribe unnecessary antibiotics

Reuters

antibiotic resistance

Flag link:

Taking on biodefense threats, antibiotics maker Spero inks $54M in government deals

Taking on biodefense threats, antibiotics maker Spero inks $54M in government deals

Endpoints

biodefense drugs

defense contracts

Flag link:

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Endpoints

Flag link:

As drug resistance grows, combining antibiotics could turn up new treatments

As drug resistance grows, combining antibiotics could turn up new treatments

Stat

antibiotic resistance

drug development

Flag link:

It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri

It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri

Fierce Pharma

Flag link:

UTILITY Therapeutics Inks License Agreement for Two Antibiotics for the US Market

UTILITY Therapeutics Inks License Agreement for Two Antibiotics for the US Market

CP Wire

UTILITY Therapeutics

Flag link:

Phage-Based Therapy - A Primer

Phage-Based Therapy - A Primer

CP Wire

antibiotic resistance

Flag link:

Pages